Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy
出版年份 2020 全文链接
标题
Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy
作者
关键词
-
出版物
Cancers
Volume 12, Issue 5, Pages 1282
出版商
MDPI AG
发表日期
2020-05-20
DOI
10.3390/cancers12051282
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
- (2019) Chara Papadaki et al. Oncotarget
- Circulating MicroRNAs in Cancer: Potential and Challenge
- (2019) Mengying Cui et al. Frontiers in Genetics
- MiR-181 family-specific behavior in different cancers: a meta-analysis view
- (2018) Cecilia Pop-Bica et al. CANCER AND METASTASIS REVIEWS
- Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
- (2018) Hao Wang et al. Clinical Epigenetics
- Regulation of miR-181a expression in T cell aging
- (2018) Zhongde Ye et al. Nature Communications
- A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer
- (2018) Jinchang Pan et al. Scientific Reports
- Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC
- (2017) Junchao Cai et al. Nature Communications
- MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
- (2017) Irina Fadejeva et al. Oncotarget
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
- (2016) Alexander A. Svoronos et al. CANCER RESEARCH
- Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
- (2016) Katrien Van Roosbroeck et al. CLINICAL CANCER RESEARCH
- A network-biology perspective of microRNA function and dysfunction in cancer
- (2016) Cameron P. Bracken et al. NATURE REVIEWS GENETICS
- MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN
- (2016) Xinying Xue et al. Oncotarget
- Role of Mir-155 in Controlling HIF-1α Level and Promoting Endothelial Cell Maturation
- (2016) Deguang Yang et al. Scientific Reports
- Bioinformatic tools for microRNA dissection
- (2015) Most Mauluda Akhtar et al. NUCLEIC ACIDS RESEARCH
- High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer
- (2015) Karol Czubak et al. Oncotarget
- DNA repair mechanisms in cancer development and therapy
- (2015) Alessandro Torgovnick et al. Frontiers in Genetics
- Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays
- (2015) Shigeshi Ono et al. Journal of Clinical Medicine
- Modulation of NF-κB/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin
- (2015) Zhenhua Yang et al. PLoS One
- The role of DNA repair pathways in cisplatin resistant lung cancer
- (2014) Shane O’Grady et al. CANCER TREATMENT REVIEWS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions
- (2014) Ioannis S. Vlachos et al. NUCLEIC ACIDS RESEARCH
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
- (2013) Andrea BISSO et al. CELL CYCLE
- Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients
- (2013) FENG GAO et al. ONCOLOGY REPORTS
- Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC
- (2013) Céline Sanfiorenzo et al. PLoS One
- Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer
- (2013) George D Cimino et al. Bioanalysis
- MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression
- (2012) Y-S Zang et al. CANCER GENE THERAPY
- High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer
- (2012) Miaomiao Yang et al. EUROPEAN JOURNAL OF CANCER
- Circulating microRNAs in cancer: origin, function and application
- (2012) Ruimin Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Assessing sample and miRNA profile quality in serum and plasma or other biofluids
- (2012) Thorarinn Blondal et al. METHODS
- The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
- (2012) Peng Wang et al. Molecular Oncology
- STRING v9.1: protein-protein interaction networks, with increased coverage and integration
- (2012) Andrea Franceschini et al. NUCLEIC ACIDS RESEARCH
- Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells
- (2011) Imran A. Babar et al. CANCER BIOLOGY & THERAPY
- MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
- (2011) S Donzelli et al. CELL DEATH AND DIFFERENTIATION
- Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
- (2011) J. S. McDonald et al. CLINICAL CHEMISTRY
- MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1 Activity during Prolonged Hypoxia
- (2011) U. Bruning et al. MOLECULAR AND CELLULAR BIOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
- (2011) Mattia Boeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miRNA response to DNA damage
- (2011) Guohui Wan et al. TRENDS IN BIOCHEMICAL SCIENCES
- miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
- (2010) Antonis Giannakakis et al. CANCER BIOLOGY & THERAPY
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
- miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
- (2010) L. Galluzzi et al. CANCER RESEARCH
- Modulation of mismatch repair and genomic stability by miR-155
- (2010) N. Valeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer
- (2009) M. Raponi et al. CANCER RESEARCH
- microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells
- (2009) P. Wang et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21
- (2009) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- Ionizing Radiation-Induced Oxidative Stress Alters miRNA Expression
- (2009) Nicole L. Simone et al. PLoS One
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search